Ladenburg Thalmann Financial Services’s Corbus Pharmaceuticals CRBP Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$10K	Buy	60 +27	+82%	+$3.99K	﹤0.01%	4476
2019 Q3	$4K	Sell	33 -63	-66%	-$11K	﹤0.01%	4756
2019 Q2	$20K	Sell	96 -366	-79%	-$78.4K	﹤0.01%	4047
2019 Q1	$96K	Sell	462 -40	-8%	-$8.82K	﹤0.01%	2910
2018 Q4	$88K	Buy	502 +335	+201%	+$66.9K	﹤0.01%	2837
2018 Q3	$38K	Sell	167 -33	-17%	-$5.33K	﹤0.01%	3500
2018 Q2	$37K	Hold	200	–	–	﹤0.01%	3460
2018 Q1	$37K	Sell	200 -126	-39%	-$28.3K	﹤0.01%	3460
2017 Q4	$70K	Buy	326 +57	+21%	+$12.2K	﹤0.01%	2995
2017 Q3	$58K	Buy	269 +139	+107%	+$27.2K	﹤0.01%	2979
2017 Q2	$24K	Hold	130	–	–	﹤0.01%	3494
2017 Q1	$32K	Buy	130 +17	+15%	+$4.17K	﹤0.01%	3232
2016 Q4	$29K	Buy	113 +100	+769%	+$22.9K	﹤0.01%	3230
2016 Q3	$3K	Buy	+13	New	+$1.62K	﹤0.01%	4346

Other funds holding CRBP

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CRBP Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Corbus Pharmaceuticals (CRBP) stake by 82% in Q4 2019, buying an estimated $3.99K and bringing the position to 60 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #4476.

Ladenburg Thalmann Financial Services first reported a position in CRBP in Q3 2016 and has held it in 14 quarters since. The position peaked at $96K in Q1 2019. 105 funds tracked by Wall St. Rank hold CRBP as of Q4 2019.

Ladenburg Thalmann Financial Services held 60 shares of Corbus Pharmaceuticals worth $10K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 27 Corbus Pharmaceuticals shares in Q4 2019, an estimated $3.99K.
Corbus Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4476 holding.
Ladenburg Thalmann Financial Services first reported a position in Corbus Pharmaceuticals in Q3 2016 and has held it in 14 quarters since.
Ladenburg Thalmann Financial Services's Corbus Pharmaceuticals position peaked at $96K in Q1 2019.
105 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.